[Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses]
- PMID: 17626756
[Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses]
Abstract
Background & objective: The early diagnosis of head and neck squamous cell carcinoma (HNSCC) is the key factor that affecting the treatment result. We performed surface-enhanced desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS) using a multi-layer artificial neural network (ANN) to develop and evaluate a proteomic diagnosis approach for HNSCC.
Methods: Serum samples from 74 HNSCC patients and 146 healthy individuals were randomized into training set (148 samples) and test set (72 samples). At first, we detected the training set of samples using SELDI mass spectrometry and WCX2 (weak cation-exchange) chips. Using a multi-layer ANN with a back propagation algorithm, we identified a proteomic pattern that could discriminate cancer from control samples in the training set. The discovered pattern was then used to determine the accuracy of the classification system in the test set.
Results: Four top-scored peaks, at m/z (mass/charge) ratio of 4 469 u, 5 924 u, 8 926 u, and 16 697 u, were finally selected as the potential biomarkers for detection of HNSCC with both sensitivity and specificity of 100.0% in the training set. The classifier predicted the HNSCC with sensitivity of 85.7%(18/21) and specificity of 96.1%(49/51) in the test set.
Conclusion: SELDI profiling is a useful tool to accurately identify patients with HNSCC.
Similar articles
-
Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b. Am J Clin Oncol. 2008. PMID: 18391596
-
Application of serum SELDI proteomic patterns in diagnosis of lung cancer.BMC Cancer. 2005 Jul 20;5:83. doi: 10.1186/1471-2407-5-83. BMC Cancer. 2005. PMID: 16029516 Free PMC article.
-
Serum protein profile analysis in patients with head and neck squamous cell carcinoma.Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):390-7. doi: 10.1001/archotol.132.4.390. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16618908 Clinical Trial.
-
[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].Bull Cancer. 2005 Sep;92(9):763-8. Bull Cancer. 2005. PMID: 16203265 Review. French.
-
[Proteomics and breast cancer].Gynecol Obstet Fertil. 2006 Dec;34(12):1161-9. doi: 10.1016/j.gyobfe.2006.09.027. Epub 2006 Nov 22. Gynecol Obstet Fertil. 2006. PMID: 17123853 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical